pentobarbital will reduce the level or outcome of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.
pentobarbital will reduce the extent or influence of paclitaxel protein certain by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.
pentobarbital will minimize the extent or influence of nateglinide by impacting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Observe.
pentobarbital will lower the extent or effect of quinidine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will minimize the extent or result of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not proposed; powerful cytochrome P450 enzyme inducers lessen systemic publicity to roflumilast and may decrease the therapeutic effectiveness
pentobarbital will lessen the extent or outcome of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will increase toxicity of buprenorphine, lengthy-performing injection by pharmacodynamic synergism. Modify Therapy/Keep an eye on Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants improves threat of adverse reactions such as overdose, respiratory despair, and Loss of life. Cessation of benzodiazepines or other CNS depressants is favored in most cases.
pentobarbital will lower the extent or result of paclitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
pentobarbital will lessen the level or impact of cinacalcet by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will decrease the extent or influence of imatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
pentobarbital will lessen the level or impact of itraconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.
pentobarbital will lower the level or outcome of ambrisentan here by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.
pentobarbital will lessen the level or impact of carvedilol by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Check.
pentobarbital will decrease the extent or outcome of dapsone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.